Pacific RxTracts - June 2026

Authors

• Pacific RxTracts

Files

Description

Articles:

• FDA Approves First Non-Antipsychotic Drug for Patients with Alzheimer’s Disease Agitation
• FDA Approves Sparsentan for Focal Segmental Glomerulosclerosis
• Lunsotogene Rings in a New Era of Gene Therapy for Hearing Loss
• Sex Differences in Breakthrough Stroke Outcomes Despite Oral Anticoagulation for Atrial Fibrillation
• Asundexian for Secondary Prevention After Ischemic Stroke or TIA
• Marstacimab Prophylaxis in Hemophilia A/B with Inhibitors: A New Purpose
• FDA Approves First-in-Class Weekly Anifrolumab Autoinjector for Systemic Lupus Erythematosus 
• Cemdisiran in Generalized Myasthenia Gravis
• Medicare’s Impact on Early Sepsis Management and Discharge to Home
• Maralixibat Shows Broader Therapeutic Benefit for Children with Alagille Syndrome 
• Reaching the Littlest Patients – FDA Expands Teplizumab Approval to Children as Young as 1 with DM
• Atezolizumab Plus mFOLFOX6 in Resected Stage III dMMR Colon Cancer: The ATOMIC Phase 3 Trial 
• Relacorilant Plus Nab-Paclitaxel Improves Survival in Platinum-Resistant Ovarian Cancer 
• Nafcillin Associated with Increased Acute Kidney Injury Risk compared to Oxacillin
• Doravirine and Islatravir: Phase 3 Non-Inferiority Trial of Switching Antiretroviral Regimen
• Lutikizumab: A Promising New Treatment for Hidradenitis Suppurativa

Publication Date

6-1-2026

Volume

23

Issue

7

Pages

10

Publisher

University of the Pacific

City

Stockton, CA

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Recommended Citation

Pacific RxTracts, "Pacific RxTracts - June 2026" (2026). Pacific RxTracts. 16.
https://scholarlycommons.pacific.edu/rx-tracts/16